Literature DB >> 24217795

Oxidative stress promotes uptake, accumulation, and oligomerization of extracellular α-synuclein in oligodendrocytes.

Katharina Pukass1, Christiane Richter-Landsberg.   

Abstract

The accumulation and aggregation of α-synuclein (α-Syn) in glial cytoplasmic inclusions originating in oligodendrocytes is a characteristic hallmark of multiple system atrophy, a progressive adult onset neurodegenerative disorder. The origin of α-Syn deposition in oligodendrocytes in multiple system atrophy is still unclear, but the uptake of α-Syn from the environment after neuronal secretion has been discussed. The present study was undertaken to investigate the consequences of α-Syn uptake from the environment in cultured oligodendroglial cells and its localization and potential to form intracellular aggregates in the absence or presence of the microtubule-associated protein tau, which has been demonstrated to act synergistically with α-Syn. Primary rat brain oligodendrocytes and clonal oligodendroglial OLN-93 cells were incubated with human recombinant soluble and pre-aggregated α-Syn. The data show that oligodendrocytes are capable to take up and internalize soluble and pre-aggregated α-Syn from their growth medium. In a time-dependent manner, α-Syn oligomerizes and small intracellular aggregates are formed. These do not exert cytotoxic responses or mitochondrial impairment. Oxidative stress exerted by hydrogen peroxide further promotes α-Syn oligomer formation and leads to an enlargement of the aggregates. This process is not affected or modified by the presence of tau in OLN-93 cells. Furthermore, membrane lipid modification by docosahexaenoic acid promotes α-Syn uptake and oligomerization, indicating that changing the membrane lipid composition and structure contributes to the protein aggregation process and pathological events. Hence, although α-Syn taken up by oligodendrocytes from the environment is not toxic per se, under conditions of oxidative stress, which might occur during chronic disease progression and aging, aggregates are enlarged and eventually may contribute to cytotoxicity and cellular death.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24217795     DOI: 10.1007/s12031-013-0154-x

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  69 in total

1.  alpha-synuclein is developmentally expressed in cultured rat brain oligodendrocytes.

Authors:  C Richter-Landsberg; M Gorath; J Q Trojanowski; V M Lee
Journal:  J Neurosci Res       Date:  2000-10-01       Impact factor: 4.164

2.  Tau immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.

Authors:  A Takeda; N Arai; T Komori; E Iseki; S Kato; M Oda
Journal:  Neurosci Lett       Date:  1997-09-26       Impact factor: 3.046

3.  Alpha-synuclein overexpression in oligodendrocytic cells results in impaired adhesion to fibronectin and cell death.

Authors:  Kyoko Tsuboi; John J Grzesiak; Michael Bouvet; Makoto Hashimoto; Eliezer Masliah; Clifford W Shults
Journal:  Mol Cell Neurosci       Date:  2005-06       Impact factor: 4.314

4.  Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein.

Authors:  He-Jin Lee; Ji-Eun Suk; Eun-Jin Bae; Jung-Ho Lee; Seung R Paik; Seung-Jae Lee
Journal:  Int J Biochem Cell Biol       Date:  2008-01-20       Impact factor: 5.085

5.  Lipid constituents in oligodendroglial cells alter susceptibility to H2O2-induced apoptotic cell death via ERK activation.

Authors:  A Brand; S Gil; R Seger; E Yavin
Journal:  J Neurochem       Date:  2001-02       Impact factor: 5.372

6.  Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation.

Authors:  S Kanda; J F Bishop; M A Eglitis; Y Yang; M M Mouradian
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

7.  Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy.

Authors:  Nadia Stefanova; Markus Reindl; Manuela Neumann; Christian Haass; Werner Poewe; Philipp J Kahle; Gregor K Wenning
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

8.  Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.

Authors:  Omar M A El-Agnaf; Sultan A Salem; Katerina E Paleologou; Leanne J Cooper; Nigel J Fullwood; Mark J Gibson; Martin D Curran; Jennifer A Court; David M A Mann; Shu-ichi Ikeda; Mark R Cookson; John Hardy; David Allsop
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

Review 9.  Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications.

Authors:  Daniel M Skovronsky; Virginia M-Y Lee; John Q Trojanowski
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

10.  Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells.

Authors:  Kelvin C Luk; Cheng Song; Patrick O'Brien; Anna Stieber; Jonathan R Branch; Kurt R Brunden; John Q Trojanowski; Virginia M-Y Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-05       Impact factor: 11.205

View more
  18 in total

1.  FTY720-Mitoxy reduces toxicity associated with MSA-like α-synuclein and oxidative stress by increasing trophic factor expression and myelin protein in OLN-93 oligodendroglia cell cultures.

Authors:  Javier Vargas-Medrano; Ismael Segura-Ulate; Barbara Yang; Ramesh Chinnasamy; Jeffrey B Arterburn; Ruth G Perez
Journal:  Neuropharmacology       Date:  2019-07-07       Impact factor: 5.250

2.  3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing α-Synuclein.

Authors:  Yunden Jinsmaa; Risa Isonaka; Yehonatan Sharabi; David S Goldstein
Journal:  J Pharmacol Exp Ther       Date:  2019-11-19       Impact factor: 4.030

3.  Autophagy mediates the clearance of oligodendroglial SNCA/alpha-synuclein and TPPP/p25A in multiple system atrophy models.

Authors:  Panagiota Mavroeidi; Fedra Arvanitaki; Maria Vetsi; Stefan Becker; Dimitrios Vlachakis; Poul Henning Jensen; Leonidas Stefanis; Maria Xilouri
Journal:  Autophagy       Date:  2022-01-09       Impact factor: 13.391

4.  DOPAL is transmissible to and oligomerizes alpha-synuclein in human glial cells.

Authors:  Yunden Jinsmaa; Patricia Sullivan; Yehonatan Sharabi; David S Goldstein
Journal:  Auton Neurosci       Date:  2015-12-31       Impact factor: 3.145

5.  Inhibition of UCH-L1 in oligodendroglial cells results in microtubule stabilization and prevents α-synuclein aggregate formation by activating the autophagic pathway: implications for multiple system atrophy.

Authors:  Katharina Pukaß; Christiane Richter-Landsberg
Journal:  Front Cell Neurosci       Date:  2015-05-05       Impact factor: 5.505

Review 6.  Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?

Authors:  Benjamin Ettle; Johannes C M Schlachetzki; Jürgen Winkler
Journal:  Mol Neurobiol       Date:  2015-05-13       Impact factor: 5.590

7.  Repurposing doxycycline for synucleinopathies: remodelling of α-synuclein oligomers towards non-toxic parallel beta-sheet structured species.

Authors:  Florencia González-Lizárraga; Sergio B Socías; César L Ávila; Clarisa M Torres-Bugeau; Leandro R S Barbosa; Andres Binolfi; Julia E Sepúlveda-Díaz; Elaine Del-Bel; Claudio O Fernandez; Dulce Papy-Garcia; Rosangela Itri; Rita Raisman-Vozari; Rosana N Chehín
Journal:  Sci Rep       Date:  2017-02-03       Impact factor: 4.379

8.  Higher levels of myelin phospholipids in brains of neuronal α-Synuclein transgenic mice precede myelin loss.

Authors:  Jessica Grigoletto; Katharina Pukaß; Ayelet Gamliel; Dana Davidi; Rachel Katz-Brull; Christiane Richter-Landsberg; Ronit Sharon
Journal:  Acta Neuropathol Commun       Date:  2017-05-08       Impact factor: 7.801

Review 9.  Glia and alpha-synuclein in neurodegeneration: A complex interaction.

Authors:  Dominik Brück; Gregor K Wenning; Nadia Stefanova; Lisa Fellner
Journal:  Neurobiol Dis       Date:  2015-03-10       Impact factor: 5.996

Review 10.  Oxidative stress and Parkinson's disease.

Authors:  Javier Blesa; Ines Trigo-Damas; Anna Quiroga-Varela; Vernice R Jackson-Lewis
Journal:  Front Neuroanat       Date:  2015-07-08       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.